HQY (HealthEquity) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HQY HealthEquity Inc HQY
96 GF Score
Price $94.25
GF Value $106.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is HealthEquity Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HealthEquity  (NAS:HQY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


HealthEquity Cyclically Adjusted PS Ratio Related Terms


HealthEquity Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for HealthEquity's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Cyclically Adjusted PS Ratio Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.15 10.14 10.54 12.98 8.64

HealthEquity Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.38 9.76 8.56 7.76 9.22

HQY vs TXG, HNGE, WAY: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, HealthEquity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HealthEquity's Cyclically Adjusted PS Ratio falls into.


HQY
96GF Score
HealthEquity Inc HQY
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

HealthEquity's Cyclically Adjusted Revenue per Share for the quarter that ended in Jul. 2026 is calculated as:

For example, HealthEquity's adjusted Revenue per Share data for the three months ended in Jul. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jul. 2026 (Change)*Current CPI (Jul. 2026)
=4.175/333.9180*333.9180
=4.175

Current CPI (Jul. 2026) = 333.9180.

HealthEquity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201610 0.722 241.729 0.997
201701 0.772 242.839 1.062
201704 0.903 244.524 1.233
201707 0.921 244.786 1.256
201710 0.918 246.663 1.243
201801 0.970 247.867 1.307
201804 1.115 250.546 1.486
201807 1.121 252.006 1.485
201810 1.103 252.885 1.456
201901 1.189 251.712 1.577
201904 1.362 255.548 1.780
201907 1.321 256.571 1.719
201910 2.228 257.346 2.891
202001 2.839 257.971 3.675
202004 2.628 256.389 3.423
202007 2.433 259.101 3.136
202010 2.304 260.388 2.955
202101 2.395 261.582 3.057
202104 2.253 267.054 2.817
202107 2.265 273.003 2.770
202110 2.154 276.589 2.600
202201 2.429 281.148 2.885
202204 2.448 289.109 2.827
202207 2.441 296.276 2.751
202210 2.555 298.012 2.863
202301 2.760 299.170 3.081
202304 2.839 303.363 3.125
202307 2.821 305.691 3.081
202310 2.861 307.671 3.105
202401 3.001 308.417 3.249
202404 3.256 313.548 3.468
202407 3.383 314.540 3.591
202410 3.390 315.664 3.586
202501 3.497 317.671 3.676
202504 3.742 320.795 3.895
202507 3.713 323.048 3.838
202510 3.704 0.000
202601 3.877 325.252 3.980
202604 4.170 333.020 4.181
202607 4.175 333.918 4.175

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is HealthEquity (HQY) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of $94.25 is trading 11.8% below its estimated GF Value™ of $106.91. GuruFocus considers HealthEquity to be Modestly Undervalued.

Key valuation signals for HQY:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $106.91 vs. price of $94.25 (11.8% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the HQY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges 2HE:Germany
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
96GF Score

Get the complete analysis for HQY

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$94.25
Price
$106.91
GF Value